Modeling Insertional Mutagenesis Using Gene Length and Expression in Murine Embryonic Stem Cells

• Alex S. Nord ,

  *To whom correspondence should be addressed. E-mail: nordalex@u.washington.edu (AN); bconklin@gladstone.ucsf.edu (BC)

  Affiliations Department of Medicine, MacDonald Medical Research Laboratories, University of California at Los Angeles, California, United States of America, Gladstone Institute of Cardiovascular Disease, San Francisco, California, United States of America, Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, University of California at San Francisco, California, United States of America

  ⨯
• Karen Vranizan,

  Affiliations Gladstone Institute of Cardiovascular Disease, San Francisco, California, United States of America, Functional Genomics Laboratory, University of California at Berkeley, California, United States of America

  ⨯
• Whittemore Tingley,

  Affiliations Gladstone Institute of Cardiovascular Disease, San Francisco, California, United States of America, Department of Medicine, University of California at San Francisco, California, United States of America

  ⨯
• Alexander C. Zambon,

  Affiliations Gladstone Institute of Cardiovascular Disease, San Francisco, California, United States of America, Department of Medicine, University of California at San Francisco, California, United States of America

  ⨯
• Kristina Hanspers,

  Affiliations Gladstone Institute of Cardiovascular Disease, San Francisco, California, United States of America, Department of Medicine, University of California at San Francisco, California, United States of America

  ⨯
• Loren G. Fong,

  Affiliation Department of Medicine, MacDonald Medical Research Laboratories, University of California at Los Angeles, California, United States of America

  ⨯
• Yan Hu,

  Affiliation Department of Medicine, MacDonald Medical Research Laboratories, University of California at Los Angeles, California, United States of America

  ⨯
• Peter Bacchetti,

  Affiliation Department of Epidemiology and Biostatistics, University of California at San Francisco, California, United States of America

  ⨯
• Thomas E. Ferrin,

  Affiliation Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, University of California at San Francisco, California, United States of America

  ⨯
• Patricia C. Babbitt,

  Affiliation Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, University of California at San Francisco, California, United States of America

  ⨯
• Scott W. Doniger,

  Affiliations Gladstone Institute of Cardiovascular Disease, San Francisco, California, United States of America, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• William C. Skarnes,

  Affiliation Wellcome Trust Sanger Institute Hinxton, Cambridge, United Kingdom

  ⨯
• Stephen G. Young,

  Affiliation Department of Medicine, MacDonald Medical Research Laboratories, University of California at Los Angeles, California, United States of America

  ⨯
• Bruce R. Conklin

  *To whom correspondence should be addressed. E-mail: nordalex@u.washington.edu (AN); bconklin@gladstone.ucsf.edu (BC)

  Affiliations Gladstone Institute of Cardiovascular Disease, San Francisco, California, United States of America, Department of Medicine, University of California at San Francisco, California, United States of America, Department of Molecular and Cellular Pharmacology, University of California at San Francisco, California, United States of America

  ⨯